InvestorsHub Logo
Followers 22
Posts 7075
Boards Moderated 0
Alias Born 05/14/2011

Re: ChillingPenguin post# 839

Tuesday, 11/09/2021 12:59:40 AM

Tuesday, November 09, 2021 12:59:40 AM

Post# of 892
Yeah Chillin', disappointed in no trial report on our Sarcoma trial, which is still due. We had the last report back in April where it rated a NON-Futile grade.

Down below are links to RAFAEL PHARMA BAD NEWS. From April and now. Can be a big issue for us. Hole not.

The 10Q filed by TYME today is positive in tone on our shot with sarcoma. And has a lot moe technical data than we ever got from last board

I got a grudge with those boys honestly. Side stepped a lot of shit. Big shake up DID point to issues.

The DOWN TO BUSINESS style by Chnninghzm.

We had the recent 100k buy in by one insider. I need more of that for comfort. Check out the links kn RAFAEL info only. They're on hitting the glucose side we're Tyrosine.

May be a reason why we dropped our aelf-sponsored pancreatic cancer trial.

Good Luck To All of us.



Phase 3 ARMADA 2000 Trial of Devimistat in Relapsed/Refractory AML to Continue

https://www.onclive.com/view/phase-3-armada-2000-trial-of-devimistat-in-relapsed-refractory-aml-to-continue

Rafael Pharma Shares Down 75% After Pancreatic Cancer Trial Didn't Meet Primary Endpoint - MarketWatch

https://www.marketwatch.com/story/rafael-pharma-shares-down-75-after-pancreatic-cancer-trial-didn-t-meet-primary-endpoint-271635424625